Patient Listening Session on CIDP

On June 5th, 2024, the GBS|CIDP Foundation International organized a patient-led listening session on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). With attendance from the National Institute of Health (NIH) and 23 FDA offices, panelists were at the heart of the meeting to express various aspects of life with CIDP, including:

• Immunoglobulin Therapy and Side Effects
• Symptoms and Residuals of CIDP
• Relapses and their Causes
• The Physical and Emotional Toll of the Diagnostic Process

For more information on the Patient Listening Session and to access the event summary, visit the Voice of the Patient meeting page.